Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignanciesSAUTER, Craig; BARKER, Juliet N.Current opinion in hematology. 2008, Vol 15, Num 6, pp 568-575, issn 1065-6251, 8 p.Article

Cord blood transplants: one, two or more units?AVERY, Sharon; BARKER, Juliet N.Current opinion in hematology. 2010, Vol 17, Num 6, pp 531-537, issn 1065-6251, 7 p.Article

Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignanciesBARKER, Juliet N; SCARADAVOU, Andromachi; STEVENS, Cladd E et al.Blood. 2010, Vol 115, Num 9, pp 1843-1849, issn 0006-4971, 7 p.Article

Umbilical cord blood transplantation: current practice and future innovationsBARKER, Juliet N; WAGNER, John E.Critical reviews in oncology/hematology. 2003, Vol 48, Num 1, pp 35-43, issn 1040-8428, 9 p.Article

How I treat: the selection and acquisition of unrelated cord blood graftsBARKER, Juliet N; BYAM, Courtney; SCARADAVOU, Andromachi et al.Blood. 2011, Vol 117, Num 8, pp 2332-2339, issn 0006-4971, 8 p.Article

Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?GREWAL, Satkiran S; BARKER, Juliet N; DAVIES, Stella M et al.Blood. 2003, Vol 101, Num 11, pp 4233-4244, issn 0006-4971, 12 p.Article

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survivalWAGNER, John E; BARKER, Juliet N; ORCHARD, Paul J et al.Blood. 2002, Vol 100, Num 5, pp 1611-1618, issn 0006-4971, 8 p.Article

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancyBARKER, Juliet N; WEISDORF, Daniel J; DEFOR, Todd E et al.Blood. 2005, Vol 105, Num 3, pp 1343-1347, issn 0006-4971, 5 p.Article

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow : results of a matched-pair analysisBARKER, Juliet N; DAVIES, Stella M; DEFOR, Todd et al.Blood. 2001, Vol 97, Num 10, pp 2957-2961, issn 0006-4971Article

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantationBRUNSTEIN, Claudio G; WEISDORF, Daniel J; DEFOR, Todd et al.Blood. 2006, Vol 108, Num 8, pp 2874-2880, issn 0006-4971, 7 p.Article

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioningBARKER, Juliet N; WEISDORF, Daniel J; DEFOR, Todd E et al.Blood. 2003, Vol 102, Num 5, pp 1915-1919, issn 0006-4971, 5 p.Article

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allograftsAVERY, Sharon; WEIJI SHI; LUBIN, Marissa et al.Blood. 2011, Vol 117, Num 12, pp 3277-3285, issn 0006-4971, 9 p.Article

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytesBARKER, Juliet N; DOUBROVINA, Ekaterina; SAUTER, Craig et al.Blood. 2010, Vol 116, Num 23, pp 5045-5049, issn 0006-4971, 5 p.Article

Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantationJACOBSON, Pamala; ROGOSHESKE, John; MCGLAVE, Philip et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 5, pp 486-500, issn 0009-9236, 15 p.Article

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV⁺ lymphomas after allogeneic hematopoietic cell transplantationDOUBROVINA, Ekaterina; OFLAZ-SOZMEN, Banu; BOULAD, Farid et al.Blood. 2012, Vol 119, Num 11, pp 2644-2656, issn 0006-4971, 13 p.Article

An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftmentELDJEROU, Lamis K; CHAUDHURY, Sonali; BAISRE-DE LEON, Ada et al.Blood. 2010, Vol 116, Num 19, pp 3999-4006, issn 0006-4971, 8 p.Article

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome : A comparative clinical analysisFLYNN, Catherine M; HIRSCH, Betsy; WEISDORF, Daniel et al.American journal of hematology. 2007, Vol 82, Num 10, pp 867-872, issn 0361-8609, 6 p.Article

Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adultsBARKER, Juliet N; DAVIES, Stella M; DEFOR, Todd E et al.British journal of haematology. 2002, Vol 118, Num 1, pp 101-107, issn 0007-1048Article

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution studySEO, Susan K; KUN XIAO; HUANG, Yao-Ting et al.The Journal of infection. 2014, Vol 69, Num 4, pp 341-351, issn 0163-4453, 11 p.Article

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensityBRUNSTEIN, Claudio G; WAGNER, John E; WEISDORF, Daniel J et al.Blood. 2009, Vol 113, Num 22, pp 5628-5634, issn 0006-4971, 7 p.Article

Umbilical cord blood transplantation after nonmyeloablative conditioning : impact on transplantation outcomes in 110 adults with hematologic disease. CommentarySHPALL, Elizabeth; DE LIMA, Marcos; MCGLAVE, Philip B et al.Blood. 2007, Vol 110, Num 8, issn 0006-4971, 2789-2790, 3064-3070 [9 p.]Article

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaLAUGHLIN, Mary J; EAPEN, Mary; MARKS, David I et al.The New England journal of medicine. 2004, Vol 351, Num 22, pp 2265-2275, issn 0028-4793, 11 p.Article